Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wang Xiaodong −$46.8M Director sold 100% of stake
  2. Lee Chan Henry −$865K SVP, General Counsel sold 100% of stake
  3. Ball Titus B. −$679K Principal Accounting Officer sold 100% of stake
  4. Wu Xiaobin −$106K President and COO sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-15 Liang Howard CFO & Chief Strategy Officer Sale −6,994 $344.38 $2.4M 5,606
2021-01-15 Liang Howard CFO & Chief Strategy Officer Sale −5,606 $345.54 $1.9M 0
2021-01-15 Liang Howard CFO & Chief Strategy Officer Option exercise · Stock Option (Right to Buy) −163,800 649,000
2021-01-14 Liang Howard CFO & Chief Strategy Officer Option exercise +1,400 $6.50 $9K 1,400
2021-01-14 Liang Howard CFO & Chief Strategy Officer Sale −1,100 $344.28 $379K 300
2021-01-14 Liang Howard CFO & Chief Strategy Officer Sale −300 $345.15 $104K 0
2021-01-14 Liang Howard CFO & Chief Strategy Officer Option exercise · Stock Option (Right to Buy) −18,200 812,800
2021-01-04 BAKER BROS. ADVISORS LP Director Sale −10,060 $220.50 $2.2M 968,943
2021-01-04 BAKER BROS. ADVISORS LP Director Sale −111,094 $220.50 $24.5M 10,699,954
2020-12-29 Huang Jane CMO, Hematology Option exercise +1,500 $29.49 $44K 1,500
2020-12-29 Huang Jane CMO, Hematology Sale −200 $244.90 $49K 1,300
2020-12-29 Huang Jane CMO, Hematology Sale −300 $246.02 $74K 1,000
2020-12-29 Huang Jane CMO, Hematology Sale −200 $247.98 $50K 800
2020-12-29 Huang Jane CMO, Hematology Sale −200 $249.88 $50K 600
2020-12-29 Huang Jane CMO, Hematology Sale −300 $251.58 $75K 300
2020-12-29 Huang Jane CMO, Hematology Sale −300 $252.86 $76K 0
2020-12-29 Huang Jane CMO, Hematology Option exercise · Share Option (Right to Buy) −19,500 324,575
2020-12-18 AMGEN INC 10% owner Grant or award +25,762 $260.95 $6.7M 18,778,273
2020-12-17 AMGEN INC 10% owner Grant or award +74,624 $260.54 $19.4M 18,752,511
2020-12-16 AMGEN INC 10% owner Grant or award +85,573 $248.26 $21.2M 18,677,887

Page 74 of 99 · 1,972 trades